A Cure for Prostate Cancer

DSC02266The Cancer Research Center (CRC) of Columbia, Missouri is an internationally recognized institution serving the public since 1962. CRC is devoted to the field of cancer research, early detection and education.

While our work is scientific, our incentive stems from a genuine concern for cancer patients and the abuse of human dignity they endure. Relying on the latest technology, CRC scientists believe it is possible to fight cancer by strengthening the body’s natural disease-fighting processes. We seek ways to detect cancer at its most basic stages and to deliver the benefits of science to individuals in their own communities. Currently CRC’s scientists are exploring a novel approach to treating prostate cancer using a genetically modified Salmonella typhimurium. The Cancer Research Center’s therapeutic Salmonella strain (CRC2631) was naturally tempered during 40 years of storage prior to meticulous genetic modifications to further eliminate toxcity and enchance its tumor destroying ability. The bacteria while being attenuated (non-toxic) have an uncanny ability to distinguish healthy cells from cancerous cells and preferentially replicates within solid tumors (1000:1) compared to non-cancerous tissue. Our scientists are very excited since current prostate cancer treatments have been partially effective only when the cancer is diagnosed early. For example, hormone therapy such as chemotherapy with Taxol is often effective in the early stages of prostate cancer; however, most men develop tumors that do not respond to this treatment within two years after the onset of the disease. Therefore alternative treatments and approaches are greatly needed In the not so distant future, chemotherapy may be a thing of the past and cancer patients will only have to get an injection of tumor seeking bacteria every couple weeks. Imagine, no hair loss or loss of healthy cells. Innovative cancer therapies, just another way we’re fighting cancer, hoping you won’t need to.